1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Inclusion and exclusion criteria for the presented series of patients treated with p64
Criteria for the p64 Treatment and Analysis in this Series
Inclusion
    Intracranial saccular sidewall aneurysm as treatment target
    Aneurysms unruptured or at least not in the acute phase after rupture
    Extra- or intradural symptomatic aneurysm
    Asymptomatic intradural aneurysms, thus carrying a potential risk of intracranial rupture
    Anticipated difficulty of coil or clip treatment (eg, complex aneurysm morphology, wide neck, dome-to-neck ratio of <1.2, small size, difficult surgical access)
    No previous treatment or any previous treatment directed at the aneurysm sac without complete occlusion of the aneurysm from circulation
     No previous treatment to the parent vessel
    An ability and willingness of the patient to take the necessary medication for midterm dual platelet function inhibition
Exclusion
    Bifurcation-type aneurysm or fusiform vessel dilation as a treatment target
    Implants other than p64 used
    Aneurysm rupture ≤30 days prior to the p64 treatment
    Extradural asymptomatic aneurysm
    Anticipated ease or sufficiency of clip or coil treatment
    Previous implantation of stents or flow diverters to the target-vessel segment